Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 509,000 | 1,672,100 | 1,677,500 | 1,684,000 | 1,659,900 |
| Cost of Goods | 251,200 | 1,123,500 | 1,065,300 | 1,081,500 | 1,069,100 |
| Gross Profit | 257,800 | 548,600 | 612,200 | 602,500 | 590,800 |
| Operating Expenses | 393,700 | 454,800 | 387,200 | 375,000 | 380,200 |
| Operating Income | -135,700 | 94,300 | 225,300 | 228,000 | 210,700 |
| Interest Expense | 33,100 | 6,000 | 100 | 800 | 200 |
| Other Income | 300 | 2,900 | 2,600 | 2,600 | 4,100 |
| Pre-tax Income | -168,500 | 91,200 | 227,800 | 229,800 | 214,600 |
| Income Tax | -67,300 | 64,100 | 73,200 | 77,200 | 72,200 |
| Net Income Continuous | -101,200 | 27,100 | 154,600 | 152,600 | 142,400 |
| Net Income Discontinuous | -325,100 | N/A | N/A | N/A | N/A |
| Net Income | $-426,300 | $27,100 | $154,600 | $152,600 | $142,400 |
| EPS Basic Total Ops | -9.15 | 0.58 | 3.32 | 3.28 | N/A |
| EPS Basic Continuous Ops | -2.17 | 0.58 | 3.32 | 3.28 | N/A |
| EPS Basic Discontinuous Ops | -6.98 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -9.15 | 0.58 | 3.32 | 3.28 | N/A |
| EPS Diluted Continuous Ops | -2.17 | 0.58 | 3.32 | 3.28 | N/A |
| EPS Diluted Discontinuous Ops | -6.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $403,700 | $179,700 | $294,500 | $285,600 | $261,800 |